Published in Cell Immunol on March 15, 1976
In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest (1967) 10.26
Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function. J Clin Invest (1967) 9.01
Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man. J Exp Med (1981) 6.82
Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors. J Exp Med (1976) 5.50
Inhibition of Bax channel-forming activity by Bcl-2. Science (1997) 5.10
Acute poststreptococcal glomerulonephritis: immune deposit disease. J Clin Invest (1966) 4.64
Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet (1968) 4.41
Thymus-dependent membrane antigens in man: inhibition of cell-mediated lympholysis by monoclonal antibodies to TH2 antigen. Proc Natl Acad Sci U S A (1981) 4.38
The functions of the thymus system and the bursa system in the chicken. J Exp Med (1966) 4.07
Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function. Lancet (1966) 3.97
The IgA system. I. Studies of the transport and immunochemistry of IgA in the saliva. J Exp Med (1966) 3.97
Primary immunodeficiencies. Report of a World Health Organization Committee. Pediatrics (1971) 3.69
Wiskott-Aldrich syndrome. An immunologic deficiency disease involving the afferent limb of immunity. Am J Med (1968) 3.54
A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature (2001) 3.28
Protection of phagocytized bacteria from the killing action of antibiotics. Nature (1966) 3.12
Renal effects of cadmium body burden of the general population. Lancet (1990) 2.90
Identification of a p69,71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemic cells. J Exp Med (1980) 2.89
Patterned delivery of immunoglobulins to surfaces using microfluidic networks. Science (1997) 2.79
Complement activity and inflammatory neutrophil exudation in man. Studies in patients with glomerulonephritis, essential hypocomplementemia and agammaglobulinemia. Int Arch Allergy Appl Immunol (1967) 2.64
The cellular immune defect in chronic mucocutaneous candidiasis. Lancet (1969) 2.53
C2 deficiency. Development of lupus erythematosus. J Clin Invest (1973) 2.52
A newly defined X-linked trait in man with demonstration of the Lyon effect in carrier females. Lancet (1967) 2.47
Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci U S A (1998) 2.46
Influence of diet on survival of mice. Proc Natl Acad Sci U S A (1976) 2.45
CD44 contributes to T cell activation. J Immunol (1989) 2.44
An NK1.1+ CD4+8- single-positive thymocyte subpopulation that expresses a highly skewed T-cell antigen receptor V beta family. Proc Natl Acad Sci U S A (1992) 2.43
Deficient immunologic functions of NZB mice. Proc Soc Exp Biol Med (1968) 2.41
Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol (1997) 2.38
The complement profile in acute glomerulonephritis systemic lupus erythematosus and hypocomplementemic chronic glomerulonephritis. Contrasts and experimental correlations. Int Arch Allergy Appl Immunol (1968) 2.38
Effects of protein insufficiency on immune responsiveness. Am J Clin Nutr (1974) 2.37
Localization of immunological complexes fixing beta1C (C3) in germinal centers of lymph nodes. J Exp Med (1969) 2.36
Chemical suppression of adaptive immunity. Adv Immunol (1967) 2.35
Growth of a pure population of mouse mast cells in vitro with conditioned medium derived from concanavalin A-stimulated splenocytes. Proc Natl Acad Sci U S A (1981) 2.33
NK1.1+ CD4+ CD8- thymocytes with specific lymphokine secretion. Eur J Immunol (1993) 2.32
Lung epithelium-specific proteins: characteristics and potential applications as markers. Am J Respir Crit Care Med (1999) 2.32
Occurrence of malignancy in immunodeficiency diseases. A literature review. Cancer (1971) 2.31
Effect of antibiotics on the bactericidal activity of human leukocytes. J Lab Clin Med (1968) 2.31
T-cell depletion of HLA-identical transplants in leukemia. Blood (1991) 2.25
Monoclonal antibody analysis of human T lymphocyte subpopulations exhibiting autologous mixed lymphocyte reaction. Proc Natl Acad Sci U S A (1981) 2.16
Suppression of B-cell differentiation by leukocytes from hypogammaglobulinemic patients. J Clin Invest (1976) 2.15
A mammalian equivalent of the avian bursa of Fabricius. Lancet (1966) 2.11
Improved tests for the evaluation of neutrophil function in human disease. J Lab Clin Med (1968) 2.11
Development and function of the immunoglobulin producing system. I. Effect of bursectomy at different stages of development on germinal centers, plasma cells, immunoglobulins and antibody production. Int Arch Allergy Appl Immunol (1969) 2.06
Kaposi's sarcoma: a review and recent developments. CA Cancer J Clin (1981) 2.05
Ubiquitin-dependent degradation of IkappaBalpha is mediated by a ubiquitin ligase Skp1/Cul 1/F-box protein FWD1. Proc Natl Acad Sci U S A (1999) 2.04
Development of "autoimmune processes" in rabbits after neonatal removal of central lymphoid tissue. Lancet (1965) 2.04
Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations. Proc Natl Acad Sci U S A (1985) 2.04
Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation. Proc Natl Acad Sci U S A (1985) 2.03
Phytohaemagglutinin unresponsiveness of lymphocytes from babies with congenital rubella. Nature (1967) 1.99
Mechanism of action of migration inhibitory factor (MIF). I. Evidence for a receptor for MIF present on the peritoneal macrophage but not on the alveolar macrophage. J Exp Med (1972) 1.99
Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood (1990) 1.98
Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci U S A (1985) 1.97
The nephrotic syndrome of childhood: immunologic, clinical, and pathologic correlations. J Clin Invest (1966) 1.96
Physical and functional interaction between WT1 and p53 proteins. Proc Natl Acad Sci U S A (1993) 1.96
Humoral and cell-mediated immune responses in fully allogeneic bone marrow chimera in mice. J Exp Med (1980) 1.94
Chronic glomerulonephritis associated with low serum complement activity (chronic hypocomplementemic glomerulonephritis). Medicine (Baltimore) (1970) 1.94
Glomerular localization and transport of aggregated proteins in mice. Lab Invest (1967) 1.94
Passive hemolysis by serum and cobra venom factor: a new mechanism inducing membrane damage by complement. Proc Natl Acad Sci U S A (1969) 1.92
Phorbol myristate acetate: a mitogen selective for a T-lymphocyte subpopulation. J Exp Med (1977) 1.91
Rosette-formation with mouse erythrocytes. II. A marker for human B and non-T lymphocytes. Clin Exp Immunol (1976) 1.87
Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol (2001) 1.85
Renal excretion of proteins and enzymes in workers exposed to cadmium. Eur J Clin Invest (1979) 1.85
A proposed classification of primary immunologic deficiencies. Am J Med (1968) 1.83
Decreased properdin activity in acute glomerulonephritis. Int Arch Allergy Appl Immunol (1969) 1.83
Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83
Abnormalities of in vitro lymphocyte responses during rubella virus infections. J Exp Med (1968) 1.82
In vivo measurement of liver and kidney cadmium in workers exposed to this metal: its significance with respect to cadmium in blood and urine. Environ Res (1981) 1.81
Assessment of renal function of workers exposed to inorganic lead, calcium or mercury vapor. J Occup Med (1980) 1.80
Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers. J Clin Invest (1993) 1.80
Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc Natl Acad Sci U S A (1996) 1.80
Pneumocystis carinii infection. Medicine (Baltimore) (1973) 1.79
Hypothalamic-pituitary-adrenal axis suppression associated with the use of inhaled fluticasone propionate. J Allergy Clin Immunol (1998) 1.77
Subpopulations of human T lymphocytes. II. Effect of thymopoietin, corticosteroids, and irradiation. Cell Immunol (1977) 1.76
Role of the thymus and other central lymphoid tissues in immunological disease. Annu Rev Med (1967) 1.76
Hereditary C2 deficiency: Genetic studies and association with the HL-A system. J Exp Med (1975) 1.75
Absence of enhancing antibody in cell mediated immunity to tumour heterografts in protein deficient rats. Nature (1971) 1.74
N.B.T. test stimulated. Lancet (1970) 1.73
B and T lymphocytes in primary immunodeficiency disease in man. J Clin Invest (1973) 1.72
Ontogeny of lymphocyte subpopulations in human fetal liver. Proc Natl Acad Sci U S A (1976) 1.71
Biosynthesis and secretion of immunoglobulins by peripheral-blood lymphocytes in severe hypogammaglobulinaemia. Lancet (1972) 1.71
Resection of lung cancer invading the diaphragm. J Thorac Cardiovasc Surg (2000) 1.70
Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet (1981) 1.70
Autoimmune phenomena and renal disease in mice. Role of thymectomy, aging, and involution of immunologic capacity. Lab Invest (1970) 1.69
Lymphoid tissue abnormalities associated with ataxia-telangiectasia. Am J Med (1966) 1.69
Subpopulations of human T lymphocytes. I. Studies in immunodeficient patients. Clin Exp Immunol (1977) 1.69
Clara cell secretory protein (CC16): characteristics and perspectives as lung peripheral biomarker. Clin Exp Allergy (2000) 1.66
Role of helper, suppressor and B-cell defects in the pathogenesis of the hypogammaglobulinemias. N Engl J Med (1978) 1.64
Epidemiological survey among workers exposed to manganese: effects on lung, central nervous system, and some biological indices. Am J Ind Med (1987) 1.63
Endocytosis of GPI-anchored proteins in human lymphocytes: role of glycolipid-based domains, actin cytoskeleton, and protein kinases. J Cell Biol (1996) 1.63
Complement and complement-like activity in lower vertebrates and invertebrates. J Exp Med (1970) 1.61
Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia. Proc Natl Acad Sci U S A (1999) 1.61
Three distinct stages of B-cell defects in common varied immunodeficiency. Proc Natl Acad Sci U S A (1982) 1.60
Lymphocyte studies in congenital thymic dysplasia: The one-way stimulation test. J Pediatr (1968) 1.59
Impairment of cell-mediated immunity functions by dietary zinc deficiency in mice. Proc Natl Acad Sci U S A (1979) 1.59
Fatal (chronic) granulomatous disease of childhood: a hereditary defect of leukocyte function. Semin Hematol (1968) 1.58
Treatment of lymphopenic hypogammaglobulinemia and bone-marrow aplasia by transplantation of allogeneic marrow. Crucial role of histocompatiility matching. N Engl J Med (1969) 1.58
Age, thymic involution, and circulating thymic hormone activity. J Clin Endocrinol Metab (1978) 1.58
Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells. Eur J Immunol (1978) 1.58